These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9062647)

  • 1. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy.
    Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR
    Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy.
    Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR
    Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts.
    Leone RJ; Straznicka M; Scholz PM; Weiss HR
    Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative metabolic and coronary flow effects of decreases in cAMP and increases in cGMP in control and renal hypertensive rabbit hearts.
    Rodriguez R; Molino B; Weiss HR; Scholz PM
    J Appl Physiol (1985); 2004 Jul; 97(1):439-45. PubMed ID: 14990553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between cGMP and myocardial O2 consumption is altered in T4-induced cardiac hypertrophy.
    Weiss HR; Rodriguez E; Tse J
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H686-91. PubMed ID: 7864195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial O2 supply and consumption in early cardiac hypertrophy of renal hypertensive rabbits.
    Cimini CM; Upsher ME; Weiss HR
    Basic Res Cardiol; 1989; 84(1):13-21. PubMed ID: 2522298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous nitric oxide reduces oxygen consumption of isolated ventricular myocytes less than other forms of guanylate cyclase stimulation.
    Gong GX; Weiss HR; Tse J; Scholz PM
    Eur J Pharmacol; 1998 Mar; 344(2-3):299-305. PubMed ID: 9600666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol-induced reduction in myocardial oxygen consumption can be attenuated by inhibiting guanylyl cyclase.
    Lazar MJ; Patel K; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):512-9. PubMed ID: 11588521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial effects of cyclic AMP phosphodiesterase inhibition are dampened in thyroxine-induced cardiac hypertrophy.
    Straznicka M; Leone RJ; Scholz PM; Weiss HR
    J Surg Res; 1998 Apr; 76(1):61-6. PubMed ID: 9695741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.
    Sadoff JD; Scholz PM; Tse J; Weiss HR
    J Clin Invest; 1996 Aug; 98(3):838-45. PubMed ID: 8698876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
    Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
    J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal muscarinic activity does not impede beta-adrenergic activation in rabbit hearts in controls or thyroxine-induced cardiac hypertrophy.
    Naim KL; Rabindranauth P; Scholz PM; Tse J; Weiss HR
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):405-11. PubMed ID: 9335397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts.
    Weiss HR; Rodriguez E; Tse J; Scholz PM
    Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):607-14. PubMed ID: 7813120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased O2 consumption and positive inotropy caused by cyclic GMP reduction are not altered after L-type calcium channel blockade.
    Leone RJ; Naim KL; Scholz PM; Weiss HR
    Pharmacology; 1998 Jan; 56(1):37-45. PubMed ID: 9467186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic nitric oxide synthase blockade desensitizes the heart to the negative metabolic effects of nitric oxide.
    Davidov T; Weiss HR; Tse J; Scholz PM
    Life Sci; 2006 Sep; 79(17):1674-80. PubMed ID: 16831448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ageing blunts the effects of nitric oxide on myocardial O2 consumption.
    Weiss HR; Lazar MJ; Tse J; Scholz PM
    Clin Exp Pharmacol Physiol; 2002 Oct; 29(10):924-30. PubMed ID: 12207573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. cGMP level that reduces cardiac myocyte O2 consumption is altered in renal hypertension.
    Straznicka M; Gong G; Tse J; Scholz PM; Weiss HR
    Am J Physiol; 1997 Oct; 273(4):H1949-55. PubMed ID: 9362265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in the level of cardiac cyclic GMP worsens contractile delay in myocardial stunning.
    Patel KN; Weiss HR; Scholz PM
    J Surg Res; 2000 Jul; 92(1):114-9. PubMed ID: 10864491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic GMP protein kinase mediates negative metabolic and functional effects of cyclic GMP in control and hypertrophied rabbit cardiac myocytes.
    Straznicka M; Gong G; Yan L; Scholz PM; Weiss HR
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):229-36. PubMed ID: 10445674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.